Andrew Worth

Andrew Worth is an experienced professional in the pharmaceutical industry with a focus on corporate development and scientific research. Since January 2017, Andrew has served in various roles at Agios Pharmaceuticals, including Associate Director of Corporate Development, Associate Director/Principal Scientist, Senior Scientist, and Scientist. Prior to this, Andrew was a Research Investigator at Bristol-Myers Squibb from August 2015 to January 2017. Andrew started their career at the University of Pennsylvania as a Graduate Student from June 2011 to April 2015, and completed a summer internship at Novartis Institutes for BioMedical Research in 2010, where the optimization of supercritical fluid chromatography parameters for drug discovery was a key project. Andrew holds a Ph.D. in Pharmacology from the University of Pennsylvania School of Medicine and a B.S. in Chemistry from Gordon College.